Alexander Rosen - Jupiter Neurosciences CoFounder Officer
| JUNS Stock | USD 1.06 0.03 2.91% |
Founder
Alexander Rosen is CoFounder Officer of Jupiter Neurosciences Common
| Age | 35 |
| Phone | 561 406 6154 |
| Web | https://jupiterneurosciences.com |
Alexander Rosen Latest Insider Activity
Tracking and analyzing the buying and selling activities of Alexander Rosen against Jupiter Neurosciences stock is an integral part of due diligence when investing in Jupiter Neurosciences. Alexander Rosen insider activity provides valuable insight into whether Jupiter Neurosciences is net buyers or sellers over its current business cycle. Note, Jupiter Neurosciences insiders must abide by specific rules, including filing SEC forms every time they buy or sell Jupiter Neurosciences'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Alexander Rosen over six months ago Insider Trading |
Jupiter Neurosciences Management Efficiency
The company has return on total asset (ROA) of (3.5494) % which means that it has lost $3.5494 on every $100 spent on assets. This is way below average. Jupiter Neurosciences' management efficiency ratios could be used to measure how well Jupiter Neurosciences manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 4 records | FOUNDER Age | ||
| Bernard MD | Genenta Science SpA | 51 | |
| Christopher Kirk | Kezar Life Sciences | 54 | |
| Jack Taunton | Kezar Life Sciences | N/A | |
| Michael Bentley | Serina Therapeutics | N/A | |
Management Performance
| Return On Asset | -3.55 |
Jupiter Neurosciences Leadership Team
Elected by the shareholders, the Jupiter Neurosciences' board of directors comprises two types of representatives: Jupiter Neurosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jupiter. The board's role is to monitor Jupiter Neurosciences' management team and ensure that shareholders' interests are well served. Jupiter Neurosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jupiter Neurosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christer Rosen, CEO CoFounder | ||
| Marshall Hayward, Chief CoFounder | ||
| Saleem CPA, CFO Secretary | ||
| Claes MD, CoChairman CoFounder | ||
| Shaun Brothers, Consulting CoFounder | ||
| Alexander Rosen, CoFounder Officer | ||
| MS MA, Chief President |
Jupiter Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Jupiter Neurosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -3.55 | ||||
| Current Valuation | 34.92 M | ||||
| Shares Outstanding | 34.43 M | ||||
| Shares Owned By Insiders | 54.10 % | ||||
| Shares Owned By Institutions | 3.94 % | ||||
| Number Of Shares Shorted | 37.87 K | ||||
| Price To Book | 617.57 X | ||||
| Gross Profit | (2.24 M) | ||||
| EBITDA | (2.19 M) | ||||
| Net Income | (2.44 M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Jupiter Stock Analysis
When running Jupiter Neurosciences' price analysis, check to measure Jupiter Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences is operating at the current time. Most of Jupiter Neurosciences' value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences' price. Additionally, you may evaluate how the addition of Jupiter Neurosciences to your portfolios can decrease your overall portfolio volatility.